Chemistry:A-PBITMO
From HandWiki
A-PBITMO is a synthetic cannabinoid receptor agonist that has been sold as a designer drug, first reported in Germany in July 2023,[1] and also subsequently identified in Russia.[2] It has an unusual 1,3-dihydrobenzimidazole-2-thione core structure which has not previously been seen in cannabinoid designer drugs.
See also
References
- ↑ "New psychoactive substances - the current situation in Europe". European Drug Report. European Union Drugs Agency (EUDA). 2024. https://www.euda.europa.eu/sites/default/files/pdf/31883_en.pdf?606797.
- ↑ (in Russian) Psychoactive products market observation. Trend analysis. (Report). Aipsin. February 2024. doi:10.13140/RG.2.2.10176.92163.
| Receptor (ligands)</small> |
| ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Transporter (modulators) |
| ||||||||||||
| Enzyme (modulators) |
| ||||||||||||
| Others |
| ||||||||||||
| |||||||||||||
 | 0.00  (0 votes) |
